Home › Crohn's Disease
Pag-aaral pangklinika para sa Crohn's Disease na nagre-recruit sa U.S.
93 pag-aaral para sa Crohn's Disease ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY35 pag-aaral
- Cleveland, OH19 pag-aaral
- St. Louis, MO19 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL19 pag-aaral
- Orlando, FL17 pag-aaral
- Houston, TX17 pag-aaral
- Atlanta, GA17 pag-aaral
- Tyler, TX16 pag-aaral
- San Diego, CA15 pag-aaral
- San Antonio, TX15 pag-aaral
- Los Angeles, CA15 pag-aaral
- Philadelphia, PA13 pag-aaral
- Colorado Springs, CO13 pag-aaral
- Durham, NC12 pag-aaral
- Providence, RI12 pag-aaral
- Tacoma, WA11 pag-aaral
- Pittsburgh, PA11 pag-aaral
- Seattle, WA11 pag-aaral
- Cincinnati, OH11 pag-aaral
- Baltimore, MD10 pag-aaral
- Washington, DC10 pag-aaral
- Indianapolis, IN10 pag-aaral
- Dallas, TX10 pag-aaral
- Lubbock, TX10 pag-aaral
- Tampa, FL10 pag-aaral
- Ann Arbor, MI9 pag-aaral
- Louisville, KY9 pag-aaral
- Chicago, IL9 pag-aaral
- Evanston, IL9 pag-aaral
- Lewisville, TX9 pag-aaral
- Rochester, MN8 pag-aaral
- Parma, OH8 pag-aaral
- New Haven, CT8 pag-aaral
- Columbus, OH8 pag-aaral
- Charlotte, NC8 pag-aaral
- Independence, MO8 pag-aaral
- Milwaukee, WI7 pag-aaral
- Lafayette, LA7 pag-aaral
- Queens, NY7 pag-aaral
Ayos sa estado
- Alabama9 pag-aaral
- Arizona17 pag-aaral
- Arkansas3 pag-aaral
- California37 pag-aaral
- Colorado18 pag-aaral
- Connecticut14 pag-aaral
- District of Columbia4 pag-aaral
- Florida27 pag-aaral
- Georgia22 pag-aaral
- Idaho4 pag-aaral
- Illinois18 pag-aaral
- Indiana13 pag-aaral
- Iowa8 pag-aaral
- Kansas11 pag-aaral
- Kentucky12 pag-aaral
- Louisiana11 pag-aaral
- Maryland15 pag-aaral
- Massachusetts27 pag-aaral
- Michigan20 pag-aaral
- Minnesota11 pag-aaral
- Mississippi3 pag-aaral
- Missouri21 pag-aaral
- Nevada8 pag-aaral
- New Hampshire3 pag-aaral
- New Jersey9 pag-aaral
- New York36 pag-aaral
- North Carolina20 pag-aaral
- Ohio30 pag-aaral
- Oklahoma8 pag-aaral
- Oregon4 pag-aaral
- Pennsylvania23 pag-aaral
- Rhode Island12 pag-aaral
- South Carolina11 pag-aaral
- South Dakota4 pag-aaral
- Tennessee10 pag-aaral
- Texas35 pag-aaral
- Utah8 pag-aaral
- Virginia15 pag-aaral
- Washington22 pag-aaral
- Wisconsin7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Nagre-recruitPhase 3
Edad 3 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Nagre-recruit
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Nagre-recruitPhase 4
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.